We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
The Societal Value of Broader Access to Antiobesity Medications.
- Authors
Kabiri, Mina; Sexton Ward, Alison; Ramasamy, Abhilasha; van Eijndhoven, Emma; Ganguly, Rahul; Smolarz, B. Gabriel; Zvenyach, Tracy; Goldman, Dana P.; Baumgardner, James R.
- Abstract
<bold>Objective: </bold>Obesity and its complications place an enormous burden on society. Yet antiobesity medications (AOM) are prescribed to only 2% of the eligible population, even though few individuals can sustain weight loss using other strategies alone. This study estimated the societal value of greater access to AOM.<bold>Methods: </bold>By using a well-established simulation model (The Health Economics Medical Innovation Simulation), the societal value of AOM for the cohort of Americans aged ≥ 25 years in 2019 was quantified. Four scenarios with differential uptake among the eligible population (15% and 30%) were modeled, with efficacy from current and next-generation AOM. Societal value was measured as monetized quality of life, productivity gains, and savings in medical spending, subtracting the costs of AOM.<bold>Results: </bold>For the 217 million Americans aged ≥ 25 years, AOM generated $1.2 trillion in lifetime societal value under a conservative scenario (15% annual uptake using currently available AOM). The introduction of next-generation AOM increased societal value to $1.9 to $2.5 trillion, depending on uptake. Finally, societal value was higher for younger individuals and Black and Hispanic individuals compared with White individuals.<bold>Conclusions: </bold>This study suggests that AOM provide substantial gains to patients and society. Policies promoting broader clinical access to and use of AOM warrant consideration to reach national goals to reduce obesity.
- Subjects
UNITED States; MEDICAL economics; MEDICAL care costs; WEIGHT loss; MEDICAL simulation; MEDICAL innovations; PREVENTION of obesity; ECONOMICS; OBESITY; RESEARCH; HEALTH services accessibility; SOCIAL change; RESEARCH methodology; COST control; SICKNESS Impact Profile; EVALUATION research; MEDICAL cooperation; COMPARATIVE studies; QUALITY of life; RESEARCH funding; ETHNIC groups; ANTIOBESITY agents; LONGITUDINAL method
- Publication
Obesity (19307381), 2020, Vol 28, Issue 2, p429
- ISSN
1930-7381
- Publication type
journal article
- DOI
10.1002/oby.22696